John Patava, PhD Chief Operating Officer

·       25 years of experience in medical research and clinical development of therapeutics products, including a 10-year period leading clinical operations at Bayer.

·       Global Head of Scientific Affairs at Sirtex Technology Pty Ltd, an Australian listed oncology company, where he managed a global clinical operations budget in excess of A$20 million.

·       Successfully delivered Sirtex’s global pivotal studies with a combined enrolment of 1103 patients, in over 200 investigator sites in 24 countries.

·       Global Head of Biosimilar Development Business Group within Quintiles.

Managed clinical trials in the indications of oncolo